Pantoprazole Dosing and Regimens for H. pylori Eradication

Standard First‑Line Regimens

The recommended pantoprazole dose for first‑line therapy is 40 mg twice daily (standard dose) combined with antibiotics for a 14‑day course. 1
Bismuth quadruple therapy (preferred) includes pantoprazole 40 mg BID, bismuth subsalicylate ~300 mg QID, metronidazole 500 mg 3–4 times daily, and tetracycline 500 mg QID for 14 days. 1
Concomitant non‑bismuth quadruple therapy uses pantoprazole 40 mg BID, amoxicillin 1000 mg BID, metronidazole 500 mg BID, and clarithromycin 500 mg BID for 14 days. 1
Levofloxacin triple therapy (rescue) comprises pantoprazole 40 mg BID, amoxicillin 1000 mg BID, and levofloxacin 500 mg once daily for 14 days. 1

For rescue treatment, a high‑dose pantoprazole regimen (80 mg BID) may be employed together with amoxicillin 2–3 g daily divided into 3–4 doses for 14 days. 1
The high‑dose dual therapy (pantoprazole 80 mg BID + amoxicillin 2–3 g/day) is an alternative rescue option. 1

Pantoprazole should be taken 30 minutes before meals or drinks on an empty stomach. 1
Concomitant use of other antacids (e.g., H₂‑receptor antagonists) should be avoided. 1

The Toronto Consensus, Maastricht V/Florence, and the American College of Gastroenterology all recommend a 14‑day duration as the preferred length for first‑line regimens to maximize eradication success. 2
While some regimens allow 10–14 days, a 14‑day course is preferred to achieve first‑attempt success. 2

Selection of the antibiotic component should be guided by local resistance patterns and the patient’s prior antibiotic exposure. 1
Clarithromycin and levofloxacin should be avoided in patients with prior exposure to these agents because of high resistance rates. 1
In regions with high dual resistance to clarithromycin and metronidazole, bismuth quadruple therapy is the preferred first‑line option. 2
After a failed regimen, clarithromycin or levofloxacin should not be reused, as resistance develops rapidly. 3
Metronidazole may be reused when combined with bismuth, owing to synergistic effects. 3